Lannett Company Inc. recalls Lisdexamfetamine Dimesylate Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
- Products
-
- Lisdexamfetamine Dimesylate Capsules
- Company
- Lannett Company Inc.
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 1608 bottles
- About this recall
- Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37